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We were very concerned to see the article by Plumb and Clayton (2013) in the 
July/August issue of The Practising Midwife. While we acknowledge that group B 
streptococcus (GBS) is a potentially serious infection in babies, some of the information in Plumb and Claytonǯs paper is both misleading and incorrect. Current 
evidence does not support the introduction of routine antenatal screening, and this 
is endorsed by the UK National Screening Committee (NSC 2012), National Institute 
of Health and Care Excellence (NICE 2012) and the Royal College of Obstetricians 
and Gynaecologists (RCOG 2012). Midwives have a professional duty to give care 
and information that is based on the best available evidence (Nursing and Midwifery 
Council (NMC) 2008) and it is therefore irresponsible to suggest, as Plumb and 
Clayton do, that midwives should give advice that contradicts this evidence. In the second paragraph of their article, Plumb and Clayton suggest that ǮFollowing GBS meningitis, 50 per cent [of babies] suffer disabilities.ǯ (owever, current evidence 
(NSC 2012) indicates that more than 85 per cent of cases of GBS meningitis are late-
onset and would not be prevented by intrapartum antibiotic prophylaxis (IAP). The 
diagram that is included as Figure 1 within the article needs careful interpretation. 
As Plumb and Clayton acknowledge, the incidence of early-onset GBS has not 
changed in recent years. While the total number of cases of GBS appears to have 
increased, this is likely to represent more effective and efficient notification, as 
much as any increase in real terms. Moreover, while the total number of reported 
cases appears to have increased from 250 to approximately 400 between 2001 and 
2011, this figure must be understood in terms of an increasing birth rate - which, for 
England and Wales in the same period, rose from 594,634 live births to 723,913 
(Office for National Statistics (ONS) 2013).  Plumb and Clayton suggest ȋp29Ȍ that ǮFifty-80 per cent of [early onset GBS] would have been preventable had existing screening guidelines been followed.ǯ These are 
alarmist statistics, but the source of the data is not identified. The use of IAP, which 
they recommend for all women with GBS colonisation or other risk factors, is not a 
benign intervention. Current evidence demonstrates that the impact of prophylaxis 
is unknown, in either the short- or long-term (NSC 2012). However, the chief 
medical officer, Dame Sally Davies, has identified antibiotic-resistant diseases as Ǯan apocalyptic threatǯ, and recently asked that antibiotic resistance be added to the 
national risk register (Sample 2013).  
We hope that midwives will have the wisdom to continue to follow professional 
guidelines, and have the confidence to reassure parents that routine antenatal 
screening for GBS is not necessary.  
Yours sincerely,  
Mary Stewart, Research Midwife, Life Study, University College London, and Mandie 
Scamell, Lecturer in Midwifery and Alison McFarlane, Professor of Women’s and 
Child’s Health, both at City University, London  
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